Shanghai, June 11th, 2008

Shanghai ChemPartner Co. Ltd. (“ChemPartner”), one of the leading contract research organizations that provide chemistry, biology, pharmacology, DMPK, process R&D, and analytical development services to global pharmaceutical and biotech companies, announced today the completion of the installation and evaluation of the cutting-edge technology platform: QPatch .

The data generated in the QPatch pilot study at ChemPartner has demonstrated that the data quality is comparable to the “gold standard” conventional manual patch recording system. This is the first ever installation and evaluation of QPatch in China. This technology platform will significantly boost our drug R&D service capabilities in ion channel drug discovery and cardiac safety evaluation of chemical compounds for our clients.

About QPatch

QPatch is developed by Sophion Bioscience based on advanced microchip technology.  It is an automated patch clamp system that can significantly accelerate the compound screening for ion channel drug targets. Such screening process is often considered as the bottleneck of drug discovery in pharmaceutical industry.